Sentinel lymph nodes and breast carcinoma: Which micrometastases are clinically significant?

American Journal of Surgical Pathology

Volumn 27, Issue 6, 2003, Pages 842-845

  Weaver, Donald L ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Breast neoplasms; Micrometastasis; Prognosis; Sentinel lymph node

Indexed keywords

BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CELL ISOLATION; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HEALTH CARE COST; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAMMOGRAPHY; PRACTICE GUIDELINE; PROGNOSIS; SENTINEL LYMPH NODE; TUMOR CELL;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 0037500400     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200306000-00018     Document Type: Conference Paper

References (16)

1. Colpaert C, Vermeulen P, Jeuris W, et al. Early distant relapse in 'node negative' breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumor. J Pathol 2001;193:442-9.
2. Cserni G. Mapping metastases in sentinel lymph nodes of breast cancer. Am J Clin Pathol 2000;113:351-4.
3. Fisher E, Palekar A, Rockette H, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4): V. Significance of Axillary Nodal Micro- and Macrometastases. Cancer 1978;42:2032-8.
4. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:966-78.
5. Greene FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Manual, 6th ed, New York: Springer, 2002.
6. Hansen NM, Grube BJ, Te W, et al. Clinical significance of axillary micrometastases in breast cancer: how small is too small [Abstract 91]? Proc ASCO 2001;20:249.
7. Huvos AG, Hutter RVP, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971;173:44-6.
8. Johnsrude IS, Dunnick NR. Lymphography. In: Johnsrude IS, Jackson DC, Dunnick NR, eds. A Practical Approach to Angiography. Boston: Little, Brown, 1987:627-50.
9. Lernevall A. Imaging of axillary lymph nodes. Acta Oncol 2000;39:277-81.
10. Lundell C, Kadir S. Lymph vessels and nodes. In: Kadir S, ed. Atlas of Normal and Variant Angiographic Anatomy. Philadelphia: WB Saunders, 1991:495-519.
11. Nasser IA, Lee AKC, Bosari S, et al. Occult axillary lymph node metastases in 'node-negative' breast carcinoma. Hum Pathol 1993;24:950-7.
12. Saphir O, Amromin GD. Obscure axillary lymph node metastases in carcinoma of the breast. Cancer 1948;1:238-41.
13. Turner RR, Ollila DW, Stern S, et al. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 1999;23:263-7.
14. Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001;92:1378-84.
15. Weaver DL, Krag DN, Ashikaga T, et al. Pathologic analysis of sentinel and non-sentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 2000;88:1099-107.
16. Weaver DL, Krag DN, Manna EA, et al. Comparison of occult micrometastasis detection in breast cancer sentinel lymph nodes using manual cytokeratin immunohistochemistry and image analysis [Abstract 221]. Mod Pathol 2002;15:55A-56A.